补肾活血汤对糖尿病肾病患者的疗效及血清CRP水平的影响被引量：12

下载PDF

导出

摘要目的探讨补肾活血汤对糖尿病肾病患者的治疗效果及血清C-反应蛋白(CRP)水平的影响。方法通过随机抽样法于本院2017年4月-2018年4月收治的糖尿病肾病患者中选取82例,依据治疗方式差异分为两组,41例患者予以洛汀新治疗作为对照组,41例患者予以补肾活血汤治疗者作为实验组,对比两组临床疗效及血清CRP水平。结果治疗后,实验组24 h尿蛋白排泄率、β2微球蛋白、尿微量白蛋白与肌酐比值较对照组低,差异有统计学意义(P<0.05);治疗后,实验组血清CRP、FIB较对照组低,差异有统计学意义(P<0.05)。结论补肾活血汤治疗糖尿病肾病可有效改善患者病情,值得选用。

作者胡维黄娟熊丹

机构地区湖南中医药大学第一附属医院内分泌科

出处《解放军预防医学杂志》 CAS 2018年第12期1610-1611,共2页 Journal of Preventive Medicine of Chinese People's Liberation Army

基金湖南省中医药大学校级课题(No.ZYYDX201742)

关键词补肾活血汤糖尿病肾病治疗效果血清CRP

分类号 R587.2 [医药卫生—内分泌]

引文网络
相关文献

参考文献5

1吕佳璇,李月红.糖尿病肾病的研究进展[J].临床内科杂志,2016,33(5):296-299. 被引量：40
2陆世龙,王龙龙,黄国东.中医药治疗早期糖尿病肾病的研究进展[J].辽宁中医杂志,2016,43(5):1101-1103. 被引量：51
3童国玉,朱大龙.糖尿病肾病国内外临床指南和专家共识解读[J].中国实用内科杂志,2017,37(3):211-216. 被引量：141
4郑筱萸主编..中药新药临床研究指导原则试行[M].北京:中国医药科技出版社,2002:392.
5聂颖颖,周景想,姜婷,宋业琳,迟伟峰,王阔.补肾活血汤剂辅助治疗高血压早期肾损害的疗效观察[J].世界中医药,2016,11(10):2023-2025. 被引量：13

二级参考文献72

1高秀林.高血压肾损害发病机制的研究进展[J].北京医学,2007,29(9):559-561. 被引量：23
2Boer I HD, Rue TC, Cleary PA, et al. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria:an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort[ J]. Arch Intern Med, 2011,171 (5) :412-420. 被引量：1
3Pavkov ME, Knowler WC, Bennett PH, et al. Increasing incidence of proteinuria and declining incidence of end-stage renal disease in diabetic Pima Indians[ J]. Kidney Int ,2006,70 (10) : 1840-1846. 被引量：1
4Stanton RC. Clinical challenges in diagnosis and management of diabetic kidney disease[J]. Am J Kidney Dis,2014,63(2 Suppl 2) :s3-21. 被引量：1
5Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications ( DCCT/EDIC ) Research Group, Nathan DM, Zinman B, et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years ' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience( 1983-2005 ) [ J]. Arch Intern Med ,2009,169 ( 14 ) : 1307-1316. 被引量：1
6Perkins BA FLH, Roshan B,et al. In patients with type 1 diabetes and new-onsetmicroalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria [ J ]. Kidney Int ,2010,77 ( 1 ) :57-64. 被引量：1
7Pezzolesi MG, Jan S, Mychaleckyj JC, et al. Insights to the genetics of diabetic nephropathy through a genome-wide association study of the GoKinD collection[ J]. Semin Nephrol,2010,30(2) : 126-140. 被引量：1
8Mcdonough CW, Palmer ND, Hicks PJ, et al. A genome-wide association study for diabetic nephropathy genes in Mrican Americans[J]. Kidney Int,2011,79(5) :563-572. 被引量：1
9Brorsson C, Pociot F. Genetics of diabetic nephropathy in diverse ethnic groups[ J]. Contrib Nephre1,2011,170:8-18. 被引量：1
10Vasylyeva TL, Chen X, Ferry RJJr. Insulin-like growth factor binding protein-3 mediates cytokine-induced mesangial cell apoptosis [ J ]. Growth Horm IGF Res,2005,15 (3) :207-214. 被引量：1